DAILY PROGRAM
Standard Time: GMT +09:00, Seoul/Tokyo
ROOM A
07:40-07:50
Opening
07:50-08:40
Plenary Session I
Chair: Myung-Ju Ahn (Sungkyunkwan Univ.)
07:50-08:40
Overcoming Resistance after 3rd Generation TKI Treatment in EGFR Mutant Non-Small Cell Lung Cancer
Suresh S. Ramalingam (Emory Univ., USA)
08:40-08:50
Break
08:50-10:10
Session I (A) Clinical Genomics
Chair: Geon Kook Lee (National Cancer Center)
08:50-09:20
Lung Pathology in the Era of Targeted Therapies in Patients with Advanced Non-Small Cell Lung Cancer
Trishe Leong (St. Vincent's Hospital Melbourne, Australia)
09:20-09:45
Experience of ROS1 CDx Platforms in the Central Laboratory of South Korea
Tae Jung Kim (The Catholic Univ. of Korea)
09:45-10:10
Clinician’s View on Next-Generation Sequencing for Rare Mutations in Lung Cancer
Shinkyo Yoon (Univ. of Ulsan)
10:10-10:30
Coffee Break
10:30-11:50
Session II (A) Oral Presentation I
Chair: In Kyu Park (Seoul National Univ.)
10:30-10:40
Exosome-GCC2 as a Promising Biomarker and Therapeutic Target for Lung Adenocarcinoma: a Multicenter study
Byeong Hyeon Choi (Korea University)
10:40-10:50
AXL Affects Tumor Growth of Lung Cancer through Regulating of Dendritic Cells
Kyungtaek Im (Asan Institute for Life Sciences)
10:50-11:00
The Expression of CEACAMs and Serum CEA Levels as Biomarkers of Postoperative Cancer Recurrence in Non-small Cell Lung Cancer
Bubse Na (Seoul National University)
11:00-11:10
Plasma GDF15 Levels Are Associated with PD-1+ T Cells in Advanced NSCLC Patient Who Treated Immunotherapy
Da Hyun Kang (Chungnam National University )
11:10-11:20
Preoperative Mediastinal Lymph Node Evaluation with Cancer-Associated Fibroblast Imaging Using Ga-68 FAPI PET/CT in Non-Small Cell Lung Cancer: A Prospective Pilot Study
Kwon Joong Na (Seoul National University)
11:20-11:30
Augmented Reality Eye Glasses Display for Real-Time Fluorescent Imaging-Guided Surgery
Ok Hwa Jeon (Korea University)
11:30-11:40
The 10-Year Journey of Non-Small Cell Lung Cancer: Real-World Experience
Daeho Choi (Sungkyunkwan University)
11:40-11:50
Application of Exosomal miRNAs as Diagnosis Biomarkers for Small Cell Lung Cancer
Dong Ha Kim (Asan Institute for Life Sciences)
11:50-12:00
Break
12:00-12:40
Satellite Symposium I [YUHAN]
Chair: Jin-Hyoung Kang (The Catholic Univ. of Korea)
12:00-12:40
Spotlighting the New 3rd generation EGFR TKI, Lazertinib: Updated Clinical Study Results & Real World Outcomes
Sun Min Lim (Yonsei Univ.)
12:40-13:00
Coffee Break
13:00-14:40
Session III (A) Indocyanine Green and Fluorescence Image-Guided Thoracic Surgery
Chair: Sukki Cho (Seoul National Univ.)
13:00-13:25
13:25-13:50
Utility and Pitfalls of Intersegmental Visibility Using Indocyanine Green in VATS Segmentectomy
Chang Young Lee (Yonsei Univ.)
13:50-14:15
Indocyanine Green Technique for Preoperative Tumor Localization in Lung Cancer
Yin-Kai Chao (Chang Gung Univ., Taiwan)
14:15-14:40
14:40-15:00
Break
15:00-16:40
Session IV (A) Advances in Radiation Oncology
Chair: Hak Choy (UT Southwestern Medical Center, USA)
15:00-15:25
FLASH: A New Paradigm in Cancer Radiation Therapy and Novel Technology for its Clinical Translation
Billy Loo (Stanford Univ., USA)
15:25-15:50
15:50-16:15
Passive Scattering or Pencil Beam Scanning Proton Therapy for Lung Cancer
Sung Ho Moon (National Cancer Center)
16:15-16:40
16:40-16:50
Break
16:50-17:40
Satellite Symposium II [MSD]
Chair: Seung Hun Jang (Hallym Univ.)
16:50-17:40
Pembrolizumab Combination Strategies in Lung Cancer: Present and Future
Bin Zhao (MSD Global Clinical Research, USA)
ROOM B
08:50-10:10
Session I (B). Details and Challenges in Sublobar Resection
Chair: Sungsoo Lee (Yonsei Univ.)
08:50-09:10
09:10-09:30
09:30-09:50
Additional Management (for Incomplete or Local Recurrence) after Sublobar Resection
Seong Yong Park (Sungkyunkwan Univ.)
09:50-10:10
Japan Clinical Oncology Group Studies about Sublobar Resection
Hisashi Saji (St. Marianna Univ., Japan)
10:10-10:30
Coffee Break
10:30-11:50
Session II (B) Upcoming Novel Therapeutics
Chair: In-Jae Oh (Chonnam National Univ.)
10:30-11:00
Antibody-Drug Conjugates: A Promising Novel Therapeutic Approach in Lung Cancer
David Planchard (Gustave Roussy, France)
11:00-11:20
J2H-2002, an Oral, Selective, and Potent Protein Degrader for the Treatment of NSCLC with Osimertinib-resistant EGFR C797S Mutations
Sumi Lee (J2HBiotech)
11:20-11:50
11:50-12:00
Break
12:00-12:40
Satellite Symposium I [YUHAN]
Chair: Jin-Hyoung Kang (The Catholic Univ. of Korea)
12:00-12:40
Spotlighting the New 3rd generation EGFR TKI, Lazertinib: Updated Clinical Study Results & Real World Outcomes
Sun Min Lim (Yonsei Univ.)
12:40-13:00
Coffee Break
13:00-14:40
Session III (B) KALC-KAI Joint Symposium: New Insight for Cancer Immunotherapy
Chair: Yeonseok Chung (Seoul National Univ.), Sei-Hoon Yang (Wonkwang Univ.)
13:00-13:30
Expanding the Benefits of Immunotherapy for Cancer: Combine and Conquer
Dan G. Duda (Harvard Medical School, USA)
13:30-14:05
14:05-14:40
Combination of Two Distinct Subsets of Peripheral Blood CD8+ T Cells from Patients with Non-Small Cell Lung Cancer Predicts Response Outcome to Immune Checkpoint Blockade Therapy
Jae Ho Cho (Chonnam National Univ.)
14:40-15:00
Break
15:00-16:40
Session IV (B) Treatment-Related Pneumonitis
Chair: Jeong Eun Lee (Chungnam National Univ.)
15:00-15:30
15:30-16:00
16:00-16:40
Optimal Management of Radiation and Drug Related Pneumonitis in Unresectable Stage III Non-Small Cell Lung Cancer Patients
William N. William (Beneficencia Portuguesa de Sao Paulo, Brazil)
16:40-16:50
Break
16:50-17:40
Satellite Symposium II [MSD]
Chair: Seung Hun Jang (Hallym Univ.)
16:50-17:40
Pembrolizumab Combination Strategies in Lung Cancer: Present and Future
Bin Zhao (MSD Global Clinical Research, USA)
ROOM C
08:50-10:10
Session I (C) Radiology : AI-Enhanced Medical Imaging in Lung Cancer
Chair: Jin Mo Goo (Seoul National Univ.)
08:50-09:20
09:20-09:45
09:45-10:10
Prognostication Using Imaging Features in Patients with Lung Cancer
Hyungjin Kim (Seoul National Univ.)
10:10-10:30
Coffee Break
10:30-11:50
Session II (C) Bronchoscopy
Chair: Bin Hwangbo (National Cancer Center)
10:30-11:00
Advanced Bronchoscopic Techniques for the Peripheral Lung Cancer
Noriaki Kurimoto (Shimane Univ. Hospital, Japan)
11:00-11:30
Medical Thoracoscopy for Malignant Pleural Effusion
Pyng Lee (National Univ. of Singapore, Singapore)
11:30-11:50
11:50-12:00
Break
12:00-12:40
Satellite Symposium I [YUHAN]
Chair: Jin-Hyoung Kang (The Catholic Univ. of Korea)
12:00-12:40
Spotlighting the New 3rd generation EGFR TKI, Lazertinib: Updated Clinical Study Results & Real World Outcomes
Sun Min Lim (Yonsei Univ.)
12:40-13:00
Coffee Break
13:00-14:40
Session III (C) Targeting Lung Cancer with Bioconjugates
Chair: Yoon Soo Chang (Yonsei Univ.)
13:00-13:25
13:25-13:50
13:50-14:15
14:15-14:40
Precision Delivery of Targeted Protein Degraders for Solid Tumors
Sung Joo Lee (Orum Therapeutics)
14:40-15:00
Break
15:00-16:40
Session IV (C) Biomarkers in Immune Checkpoint Inhibitor
Chair: Yoon Kyung Jeon (Seoul National Univ.)
15:00-15:25
15:25-15:50
15:50-16:15
Tumor Immunogenecity: Tumor Mutational Burden, Microsatellite Instability
Yasushi Goto (National Cancer Center Hospital, Japan)
16:15-16:40
Tumor Cell Gene Mutation: Druggable Mutations, STK11, MDM2, DNMT3A, CDKN2A/B, etc.
Yun-Gyoo Lee (Sungkyunkwan Univ.)
16:40-16:50
Break
16:50-17:40
Satellite Symposium II (C) [TAKEDA]
Chair: Sang-We Kim (Univ. of Ulsan)
16:50-17:40
1L Treatment Approach for Patients with ALK+Advanced Non-Small Cell Lung Cancer
Hyun-Ae Jung (Sungkyunkwan Univ.)
ROOM D
16:50-17:40
Satellite Symposium II (D) [ONO BMS]
Myung-Ju Ahn (Sungkyunkwan Univ.)
16:50-17:40
Changing Treatment Paradigm of Neoadjuvant Non-Small Cell Lung Cancer with Newly Approved OPDIVO + Chemotherapy
Mariano Provencio (Puerta de Hierro Majadahonda Univ. Hospital, Spain)
